<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font24 { font-size : 24; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">vaccine </span>
   <span class="font24">trial </span>
   <span class="font21">investigational </span>
   <span class="font19">control </span>
   <span class="font18">Ebola </span>
   <span class="font16">design </span>
   <span class="font16">disease </span>
   <span class="font16">participants </span>
   <span class="font15">trials </span>
   <span class="font15">[]. </span>
   <span class="font15">randomized </span>
   <span class="font15">{border-style </span>
   <span class="font14">direct </span>
   <span class="font14">risk </span>
   <span class="font14">vaccines </span>
   <span class="font14">effect </span>
   <span class="font14">px;} </span>
   <span class="font14">rollout </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">Health </span>
   <span class="font14">population </span>
   <span class="font13">Vaccine </span>
   <span class="font13">effects </span>
   <span class="font13">placebo </span>
   <span class="font13">However, </span>
   <span class="font13">Sciences </span>
   <span class="font13">clusters </span>
   <span class="font13">vaccine, </span>
   <span class="font13">epidemic </span>
   <span class="font13">high </span>
   <span class="font13">incidence </span>
   <span class="font13">infectious </span>
   <span class="font13">time </span>
   <span class="font13">Infectious </span>
   <span class="font13">Medicine </span>
   <span class="font13">efficacy </span>
   <span class="font13">social </span>
   <span class="font13">trial’s </span>
   <span class="font13">used </span>
   <span class="font12">Trial </span>
   <span class="font12">[,]. </span>
   <span class="font12">delayed </span>
   <span class="font12">individuals </span>
   <span class="font12">intervention </span>
   <span class="font12">scientific </span>
   <span class="font12">different </span>
   <span class="font12">epidemic, </span>
   <span class="font12">group </span>
   <span class="font12">infection </span>
   <span class="font12">stepped </span>
   <span class="font12">vaccine. </span>
   <span class="font12">(e.g., </span>
   <span class="font12">emerging </span>
   <span class="font12">indirect </span>
   <span class="font12">likely </span>
   <span class="font12">population, </span>
   <span class="font12">study </span>
   <span class="font12">Research </span>
   <span class="font12">active </span>
   <span class="font12">choices </span>
   <span class="font12">effective </span>
   <span class="font12">exposure </span>
   <span class="font12">measured </span>
   <span class="font12">measures </span>
   <span class="font12">protective </span>
   <span class="font12">px; </span>
   <span class="font12">required </span>
   <span class="font12">use </span>
   <span class="font12">value </span>
   <span class="font12">{font-family </span>
   <span class="font11">Disease </span>
   <span class="font11">available </span>
   <span class="font11">cRCT </span>
   <span class="font11">considerations </span>
   <span class="font11">controlled </span>
   <span class="font11">font-size </span>
   <span class="font11">general </span>
   <span class="font11">iRCT </span>
   <span class="font11">infection. </span>
   <span class="font11">possible </span>
   <span class="font11">pregnant </span>
   <span class="font11">receive </span>
   <span class="font11">relevant </span>
   <span class="font11">risk–benefit </span>
   <span class="font11">safety </span>
   <span class="font11">sample </span>
   <span class="font11">size </span>
   <span class="font11">transmission </span>
   <span class="font11">trial, </span>
   <span class="font11">typically </span>
   <span class="font11">vaccinated </span>
   <span class="font11">./S-()- </span>
   <span class="font11">Clinical </span>
   <span class="font11">Cluster </span>
   <span class="font11">Design </span>
   <span class="font11">General </span>
   <span class="font11">LipsitchM, </span>
   <span class="font11">Public </span>
   <span class="font11">comparison </span>
   <span class="font11">design, </span>
   <span class="font11">double; </span>
   <span class="font11">enhance </span>
   <span class="font11">epidemics. </span>
   <span class="font11">ethical </span>
   <span class="font11">factors </span>
   <span class="font11">feasibility </span>
   <span class="font11">highly </span>
   <span class="font11">important </span>
   <span class="font11">individually </span>
   <span class="font11">investigators </span>
   <span class="font11">key </span>
   <span class="font11">trial. </span>
   <span class="font11">vaccination </span>
   <span class="font11">women </span>
   <span class="font11">Department </span>
   <span class="font11">Lancet. </span>
   <span class="font11">Medical </span>
   <span class="font11">National </span>
   <span class="font11">Trials </span>
   <span class="font11">Trials. </span>
   <span class="font11">United </span>
   <span class="font11">administration </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">cluster-randomized </span>
   <span class="font11">compared </span>
   <span class="font11">considered </span>
   <span class="font11">effective, </span>
   <span class="font11">effects, </span>
   <span class="font11">especially </span>
   <span class="font11">example, </span>
   <span class="font11">fairness </span>
   <span class="font11">greater </span>
   <span class="font11">individual </span>
   <span class="font11">parallel </span>
   <span class="font11">population. </span>
   <span class="font11">randomization </span>
   <span class="font11">rapidly </span>
   <span class="font11">received </span>
   <span class="font11">solid; </span>
   <span class="font11">supplies </span>
   <span class="font11">thought </span>
   <span class="font11">trials, </span>
   <span class="font11">trials. </span>
   <span class="font11">workers </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">;(). </span>
   <span class="font11">Analysis </span>
   <span class="font11">Dis. </span>
   <span class="font11">Epidemiol. </span>
   <span class="font11">Epidemiology </span>
   <span class="font11">Ethical </span>
   <span class="font11">Harvard </span>
   <span class="font11">Individually </span>
   <span class="font11">International </span>
   <span class="font11">LipsitchM. </span>
   <span class="font11">Med. </span>
   <span class="font11">Phase </span>
   <span class="font11">Placebo </span>
   <span class="font11">Pneumococcal </span>
   <span class="font11">Randomized </span>
   <span class="font11">School </span>
   <span class="font11">Sierra </span>
   <span class="font11">Stepped </span>
   <span class="font11">Vaccination </span>
   <span class="font11">Vaccines </span>
   <span class="font11">Virus </span>
   <span class="font11">World </span>
   <span class="font11">Zika </span>
   <span class="font11">access </span>
   <span class="font11">account </span>
   <span class="font11">advance </span>
   <span class="font11">analysis </span>
   <span class="font11">and, </span>
   <span class="font11">assessment </span>
   <span class="font11">benefit </span>
   <span class="font11">bold </span>
   <span class="font11">cRCTs </span>
   <span class="font11">case </span>
   <span class="font11">circumstances, </span>
   <span class="font11">clinical </span>
   <span class="font11">collab: </span>
   <span class="font11">community </span>
   <span class="font11">comparator </span>
   <span class="font11">courier; </span>
   <span class="font11">default </span>
   <span class="font11">design: </span>
   <span class="font11">diseases. </span>
   <span class="font11">does </span>
   <span class="font11">effect, </span>
   <span class="font11">em; </span>
   <span class="font11">epidemics </span>
   <span class="font11">estimate </span>
   <span class="font11">evaluating </span>
   <span class="font11">experimental </span>
   <span class="font11">future </span>
   <span class="font11">groups </span>
   <span class="font11">health </span>
   <span class="font11">healthcare </span>
   <span class="font11">high-risk </span>
   <span class="font11">immunogenicity </span>
   <span class="font11">intervention, </span>
   <span class="font11">interventions </span>
   <span class="font11">issues </span>
   <span class="font11">know </span>
   <span class="font11">larger </span>
   <span class="font11">limited </span>
   <span class="font11">maximize </span>
   <span class="font11">order </span>
   <span class="font11">participant </span>
   <span class="font11">populations </span>
   <span class="font11">power </span>
   <span class="font11">profile </span>
   <span class="font11">protection </span>
   <span class="font11">proves </span>
   <span class="font11">pt;} </span>
   <span class="font11">research </span>
   <span class="font11">selected </span>
   <span class="font11">settings </span>
   <span class="font11">settings. </span>
   <span class="font11">statistical </span>
   <span class="font11">strategy </span>
   <span class="font11">testing </span>
   <span class="font11">unproven </span>
   <span class="font11">virus </span>
   <span class="font11">workshop </span>
  </p>
 </body>
</html>
